Journal ArticleDOI
Global Cancer Incidence and Mortality Rates and Trends—An Update
Reads0
Chats0
TLDR
Applied cancer control measures are needed to reduce rates in HICs and arrest the growing burden in LMICs, as well as for lung, colorectal, breast, and prostate cancer, although some low- and middle-income countries (LMIC) now count among those with the highest rates.Abstract:
There are limited published data on recent cancer incidence and mortality trends worldwide. We used the International Agency for Research on Cancer's CANCERMondial clearinghouse to present age-standardized cancer incidence and death rates for 2003-2007. We also present trends in incidence through 2007 and mortality through 2012 for select countries from five continents. High-income countries (HIC) continue to have the highest incidence rates for all sites, as well as for lung, colorectal, breast, and prostate cancer, although some low- and middle-income countries (LMIC) now count among those with the highest rates. Mortality rates from these cancers are declining in many HICs while they are increasing in LMICs. LMICs have the highest rates of stomach, liver, esophageal, and cervical cancer. Although rates remain high in HICs, they are plateauing or decreasing for the most common cancers due to decreases in known risk factors, screening and early detection, and improved treatment (mortality only). In contrast, rates in several LMICs are increasing for these cancers due to increases in smoking, excess body weight, and physical inactivity. LMICs also have a disproportionate burden of infection-related cancers. Applied cancer control measures are needed to reduce rates in HICs and arrest the growing burden in LMICs.read more
Citations
More filters
Journal ArticleDOI
M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer.
Michal Hensler,Lenka Kasikova,Karel Fiser,Jana Rakova,Petr Skapa,Jan Laco,Tereza Lanickova,Ladislav Pecen,Iva Truxova,Sarka Vosahlikova,Irena Moserova,Ivan Praznovec,Vit Drochytek,Martina Rehackova,Tomas Brtnicky,Lukas Rob,Vladimir Benes,Jelena Pistolic,Ludek Sojka,Ales Ryska,Catherine Sautès-Fridman,Catherine Sautès-Fridman,Wolf Hervé Fridman,Wolf Hervé Fridman,Lorenzo Galluzzi,Radek Spisek,Jitka Fucikova +26 more
TL;DR: Investigation of the clinical relevance of the immunological configuration of HGSC metastases finds M2-like TAM infiltrating metastatic sites limit clinically relevant immune responses against HGSCs.
Journal ArticleDOI
Prognostic Significance of Tumor-Infiltrating Natural Killer Cells in Solid Tumors: A Systematic Review and Meta-Analysis.
TL;DR: It is indicated that high levels of NK cell markers in solid tumor tissues could predict favorable prognosis for solid tumor patients.
Journal ArticleDOI
Colorectal liver metastasis: molecular mechanism and interventional therapy
Hui Zhou,Zhong-Tao Liu,Yongxiang Wang,Xiaoyong Wen,Eric Amador,Liqin Yuan,Xin Ran,Ling-Jing Xiong,Yuping Ran,Wei Chen,Yu Wen +10 more
TL;DR: In this article , the authors summarized the mechanisms/pathophysiology, diagnosis, and treatment of colorectal liver metastasis (CRLM) patients and provided an overview of the recent advances in understanding the molecular basis of CRLM with a special emphasis on tumor microenvironment.
Journal ArticleDOI
LncRNA-ATB promotes autophagy by activating Yes-associated protein and inducing autophagy-related protein 5 expression in hepatocellular carcinoma.
TL;DR: The expression of lncRNA-ATB was higher in HCC tissues than in normal liver tissues, and lncRNAs expression was positively correlated with tumor size, TNM stage, and poorer survival of patients with HCC.
Journal ArticleDOI
Single-Atom Catalysts for Nanocatalytic Tumor Therapy.
TL;DR: In this article, the most recent advances in nanocatalytic tumor therapy by using various types of SACs, especially their remarkable achievements in several Nanocatalysis tumor therapy-based modalities, such as chemodynamic therapy by tumor microenvironment-responsive catalytic reactions, photodynamic therapy, sonodynamic therapy and parallel catalytic therapy by parallel catalyty reactions, are reviewed by focusing on the catalytic nanoplatform construction and catalytic mechanism.
References
More filters
Journal ArticleDOI
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.
TL;DR: The results for 20 world regions are presented, summarizing the global patterns for the eight most common cancers, and striking differences in the patterns of cancer from region to region are observed.
Journal ArticleDOI
Reduced lung-cancer mortality with low-dose computed tomographic screening.
Denise R. Aberle,Amanda M. Adams,Christine D. Berg,William C. Black,Jonathan D. Clapp,Richard M. Fagerstrom,Ilana F. Gareen,Constantine Gatsonis,Pamela M. Marcus,JoRean D. Sicks +9 more
TL;DR: Screening with the use of low-dose CT reduces mortality from lung cancer, as compared with the radiography group, and the rate of death from any cause was reduced.
Journal ArticleDOI
The global health burden of infection-associated cancers in the year 2002.
TL;DR: The fraction of the different types of cancer, and of all cancers worldwide and in different regions, has been estimated using several methods; primarily by reviewing the evidence for the strength of the association (relative risk) and the prevalence of infection in different world areas.
GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet]
J Ferlay,I Soerjomataram,M Ervik,R Dikshit,S Eser,Colin Mathers,M Rebelo,D.M. Parkin,David Forman,Freddie Bray,S Elser,M Ervick,Donald Maxwell Parkin +12 more
Journal ArticleDOI
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
TL;DR: The authors update the incidence trends through 1994 and further consider the trends by age group.